Suspension of De Minimis Exemption Threatens 2.3 Million Patients
Effective October 22, U.S. Customs and Border Protection (CBP) will indefinitely suspend the 'de minimis' threshold, which previously granted expedited, duty-free entry to international packages valued below $800.
Designed broadly to collect commercial tariffs and prevent illicit narcotics from entering the country, the rule imposes registration burdens and bond requirements on international mail.
However, healthcare advocates emphasize that the primary victims will be the estimated 2.3 million Americans who legally import personal medications from Canadian licensed pharmacies.















